Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1166923

	registered interest
	date	28/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to widen the NHS England criteria under which diabetes patients can receive the Freestyle Libre glucose monitoring device on prescription to include type 2 diabetics.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	6361
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence (NICE) guidelines into consideration when making their decisions. NICE currently recommends not routinely offering self-monitoring of blood glucose levels for adults with type 2 diabetes unless the person:</p><p> </p><p>- is on insulin;</p><p>- or there is evidence of hypoglycaemic episodes;</p><p>- or the person is on medication that may increase their risk of hypoglycaemia while driving or operating machinery;</p><p>- or the person is pregnant or is planning to become pregnant.</p><p> </p><p>The evidence base for the benefits and cost-effectiveness of flash glucose monitoring for people with type 2 diabetes is still developing, and NICE will continue to monitor the evidence and relevant research.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 10:24:50 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1168790

	registered interest
	date	20/12/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of the resources allocated to the NHS Long Term Plan will be dedicated to reduce waiting times for child and adolescent mental health services.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	287
	answer	answer is ministerial correction date of answer 10/01/2020 answer text <p>The following table shows, in cash terms, the total additional funding available in each year above what was available in 2018/19:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td><td><p>2023/24</p></td></tr><tr><td><p>Long Term Plan funding for children’s and young people’s mental health - £ billion</p></td><td><p>£0</p></td><td><p>£0.193</p></td><td><p>£0.267</p></td><td><p>£0.389</p></td><td><p>£0.538</p></td><td><p>£0.739</p></td></tr><tr><td><p>NHS Revenue Departmental Expenditure Limit - £ billion, excluding. depreciation and impairment</p></td><td><p>£0</p></td><td><p>£6.2</p></td><td><p>£12.4</p></td><td><p>£18.7</p></td><td><p>£25.4</p></td><td><p>£33.9</p></td></tr></tbody></table><p>Source: NHS England</p><p> </p><p>This funding will support local organisations to maintain and build on the two existing waiting time standards for children and young people with eating disorders and for those experiencing a first episode of psychosis.</p><p> </p><p>Funding for generic children’s and young people’s mental health community services, however, has been allocated on the basis of increased activity rather than on waiting times.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 10/01/2020 14:03:39 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4079 label Biography information for Julian Sturdy

1168791

	registered interest
	date	20/12/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) monitor and (b) reduce waiting times for CAMHS services.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	288
	answer	answer is ministerial correction date of answer 09/01/2020 answer text <p>We have introduced two waiting time standards relating to mental health services for children and young people and the National Health Service is currently on track to meet both of these by April 2021.</p><p> </p><p>The first is for 95% of children (up to 19 years old) with eating disorders to receive treatment within a week for urgent cases and four weeks for routine cases. The second aims for 50% of patients of all ages experiencing a first episode of psychosis to receive treatment within two weeks of referral.</p><p> </p><p>Our Green Paper on transforming children and young people’s mental health provision, jointly published with the Department for Education, sets out how we plan to go further. We are piloting a four-week waiting time in 12 areas to improve access to children and young people’s specialist mental health services and are introducing new schools- and college-based mental health support teams.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 09/01/2020 12:18:24 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4079 label Biography information for Julian Sturdy

1169565

	registered interest
	date	08/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Suicide
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much new funding from the public purse he plans to allocate to suicide prevention under the NHS Long Term Plan.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	1431
	answer	answer is ministerial correction date of answer 17/01/2020 answer text <p>From 2019/20, we are investing £57million in suicide prevention through the NHS Long Term Plan. A breakdown of funding for each year to 2023/24 is shown in the attached table.</p><p> </p><p>This funding will see 100% of sustainability and transformation partnerships (STPs) having received investment for localised suicide reduction programmes by the end of 2022/23, and 80% of STPs having received investment for bereavement support services. By 2023/24, 100% of STPs will have received investment for both suicide reduction programmes and bereavement support services.</p><p> </p><p>Other mental health commitments in the NHS Long Term Plan will support suicide prevention, such as 24 hours a day, seven days a week crisis care for all ages available via NHS 111, and integrated community support for adults with severe mental illness.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 17/01/2020 12:52:18 answering member 1481 label Biography information for Ms Nadine Dorries attachment 1 file name pq1431 table.docx title pq1431 table
	tabling member	4079 label Biography information for Julian Sturdy

1169567

	registered interest
	date	08/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Suicide
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the regional variation in suicide rates; and what steps his Department is taking to ensure the allocation of the NHS mental health budget reflects those variations.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	1433
	answer	answer is ministerial correction date of answer 17/01/2020 answer text <p>From 2019/20 to 2023/24, we are investing a total of £57 million in suicide prevention through the NHS Long Term Plan. This will see investment in all areas of the country by 2023/24 to support local suicide prevention plans and establish suicide bereavement support services.</p><p> </p><p>The NHS Mental Health Implementation Plan 2019/20 – 2023/24 sets out how funding allocations for suicide reduction programmes will be phased through a targeted allocation process, based on rates of suicide in each sustainability and transformation partnership area, with funding amounts being based on the number of suicides in an area and as a proportion of suicides in England.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 17/01/2020 12:58:55 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4079 label Biography information for Julian Sturdy

1188677

	registered interest
	date	20/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	World Health Organization: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to make an assessment of the adequacy of the World Health Organisation’s response to initial evidence of the covid-19 outbreak in Wuhan.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	37620
	answer	answer is ministerial correction date of answer 04/05/2020 answer text <p>The World Health Organization (WHO) has an important role to play in leading the global health response. We want to see WHO continue to learn lessons on how to improve its response to global health emergencies and as such would expect a full review of all elements of their response to COVID-19 to take place once they are out of response mode, as has occurred after previous Public Health Emergencies of International Concern.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 37621 question first answered 04/05/2020 13:25:04 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1188678

	registered interest
	date	20/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	World Health Organization: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to make an assessment of whether the World Health Organisation’s decision-making regarding the covid-19 outbreak has been influenced by political considerations.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	37621
	answer	answer is ministerial correction date of answer 04/05/2020 answer text <p>The World Health Organization (WHO) has an important role to play in leading the global health response. We want to see WHO continue to learn lessons on how to improve its response to global health emergencies and as such would expect a full review of all elements of their response to COVID-19 to take place once they are out of response mode, as has occurred after previous Public Health Emergencies of International Concern.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 37620 question first answered 04/05/2020 13:25:04 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1189006

	registered interest
	date	21/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase manufacturing capacity to mass produce a potential coronavirus vaccine.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	38560
	answer	answer is ministerial correction date of answer 04/05/2020 answer text <p>The new Government ‘Vaccines Taskforce’ is working with the BioIndustry Association Taskforce to review options for increasing the capacity of domestic capability to manufacture vaccines, in response to COVID-19, including how to support the acceleration and expand the capacity of the Vaccines Manufacturing and Innovation Centre, so that it becomes operational earlier than planned and is able to manufacture population level doses.</p><p>For COVID-19, the type of vaccine manufacturing capacity needed will be determined by the nature of the vaccine that is developed and the technology used to produce the vaccines. The scale of facility needed will depend on how potent the vaccines are, and the productivity of the processes used to produce them.</p><p>This work is proceeding at pace, with the support of industry and academic partners, to ensure that we are identifying suitable capacity across different vaccine types, while those vaccines are still under development.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/05/2020 13:10:18 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1190230

	registered interest
	date	24/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that any UK-based research breakthroughs on a covid-19 vaccine are prioritised for mass production by the UK's pharmaceutical sector.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	39652
	answer	answer is ministerial correction date of answer 12/05/2020 answer text <p>The Government has established a Vaccines Taskforce to coordinate the work going on across Government, academia and industry to accelerate the development and manufacture of a COVID-19 vaccine.</p><p>Work is proceeding at pace, with the support of industry and academic partners, to ensure that the United Kingdom has capacity to deliver across different vaccine types while those vaccines are still under development.</p><p>As the Secretary of State for Business, Energy and Industrial Strategy has said, we are working closely with the industry-led BioIndustry Association Manufacturing Taskforce. It brings together a range of businesses keen to use their expertise to ensure the UK can produce a vaccine at scale, once it has been found.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/05/2020 09:53:26 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1192625

	registered interest
	date	04/05/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when and how the Government plans to communicate changes to shielding advice to people with cystic fibrosis and other people in the extremely vulnerable group during the covid-19 outbreak.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	42999
	answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>Shielding advice is kept under review, taking into account currently available evidence. We will issue further guidance about shielding and social distancing for clinically vulnerable groups as new evidence emerges.</p><p>The Government understands how challenging this period is, especially for those with long term conditions, and is doing everything possible to support the clinically extremely vulnerable. This includes clearly communicating any changes in advice for this group so those shielding are confident they are receiving the correct information for them.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:25:13 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy